{"transactions":[{"id":2662150,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:16:24.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":4172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2022 annual meeting of the Company's stockholders or June 16, 2022."}],"balance_after":12125,"source":{"system":"sec-edgar","filing":"0001171843-21-004427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321004427/ownership.xml","form_type":"4"}},{"id":2713172,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T20:31:12.000Z","date":"2021-05-12","kind":"sale","acquired":false,"shares":2000,"price":42.6,"value":85200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 12, 2021, Mr. Land sold 2,000 shares in multiple trades ranging from $42.50 to $42.72. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":7953,"source":{"system":"sec-edgar","filing":"0001171843-21-003534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321003534/ownership.xml","form_type":"4"}},{"id":2984886,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T21:08:22.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":3446,"price":36.77,"value":126709.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On November 10, 2020, Mr. Land sold 3,446 shares in multiple trades ranging from $36.71 to $36.98. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":9953,"source":{"system":"sec-edgar","filing":"0001171843-20-007934","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320007934/ownership.xml","form_type":"4"}},{"id":3244907,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T23:54:44.000Z","date":"2020-02-26","kind":"sale","acquired":false,"shares":2700,"price":42.68,"value":115236.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"On February 26, 2020, Mr. Land sold 2,700 shares in multiple trades ranging from $42.53 to $42.80. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":13399,"source":{"system":"sec-edgar","filing":"0001171843-20-001364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001364/ownership.xml","form_type":"4"}},{"id":3244906,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T23:54:44.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021."}],"balance_after":16099,"source":{"system":"sec-edgar","filing":"0001171843-20-001364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001364/ownership.xml","form_type":"4"}},{"id":3453975,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-30T20:06:50.000Z","date":"2019-07-29","kind":"sale","acquired":false,"shares":3000,"price":55.44,"value":166320.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 29, 2019, Mr. Land sold 3,000 shares in accordance with a previously-executed 10b5-1 Sales Plan."}],"balance_after":11992,"source":{"system":"sec-edgar","filing":"0001171843-19-004979","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319004979/ownership.xml","form_type":"4"}},{"id":3627462,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:34:50.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":4000,"price":33.06,"value":132240.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 26, 2019, Mr. Land sold 4,000 shares in multiple trades ranging from $32.76 to $33.13. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":14992,"source":{"system":"sec-edgar","filing":"0001171843-19-001389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001389/ownership.xml","form_type":"4"}},{"id":3627461,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:34:50.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020."}],"balance_after":18992,"source":{"system":"sec-edgar","filing":"0001171843-19-001389","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001389/ownership.xml","form_type":"4"}},{"id":4088835,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:08:41.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019."}],"balance_after":15150,"source":{"system":"sec-edgar","filing":"0001171843-18-000693","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000693/formfour.xml","form_type":"4"}},{"id":4232087,"issuer":{"id":167805,"kind":"organization","name":"BioAmber Inc.","symbol":"BIOA"},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2017-08-16T13:37:08.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The fixed combination, consisting of one share of common stock and associated warrant to purchase one share of common stock was issued at a price of $0.75."}],"balance_after":13333,"derivative":{"exercise_price":0.75,"exercise_date":"2017-08-15","expiration_date":"2022-08-15","underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001209191-17-049132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225613/000120919117049132/doc4.xml","form_type":"4"}},{"id":4232086,"issuer":{"id":167805,"kind":"organization","name":"BioAmber Inc.","symbol":"BIOA"},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-16T13:37:08.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The fixed combination, consisting of one share of common stock and associated warrant to purchase one share of common stock was issued at a price of $0.75."}],"balance_after":14833,"source":{"system":"sec-edgar","filing":"0001209191-17-049132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225613/000120919117049132/doc4.xml","form_type":"4"}},{"id":4232085,"issuer":{"id":167805,"kind":"organization","name":"BioAmber Inc.","symbol":"BIOA"},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2017-08-16T13:32:42.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The fixed combination, consisting of one share of common stock and associated warrant to purchase one share of common stock was issued at a price of $0.75."}],"balance_after":40000,"derivative":{"exercise_price":0.75,"exercise_date":"2017-08-15","expiration_date":"2022-08-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-17-049131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1225613/000120919117049131/doc4.xml","form_type":"4"}},{"id":4232084,"issuer":{"id":167805,"kind":"organization","name":"BioAmber Inc.","symbol":"BIOA"},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-16T13:32:42.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The fixed combination, consisting of one share of common stock and associated warrant to purchase one share of common stock was issued at a price of $0.75."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-17-049131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225613/000120919117049131/doc4.xml","form_type":"4"}},{"id":4315351,"issuer":{"id":167805,"kind":"organization","name":"BioAmber Inc.","symbol":"BIOA"},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-17T17:55:25.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options will vest on a quarterly basis, as follows: 25% will vest on August 11, 2017, 25% will vest on November 11, 2017, 25% will vest on February 11, 2018 and 25% will vest on May 11, 2018."}],"balance_after":36000,"derivative":{"exercise_price":2.26,"expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001209191-17-033326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1225613/000120919117033326/doc4.xml","form_type":"4"}},{"id":4425654,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-24T21:05:38.000Z","date":"2017-02-22","kind":"sale","acquired":false,"shares":2635,"price":49.08,"value":129325.8,"ownership":{"direct":true},"balance_after":13524,"source":{"system":"sec-edgar","filing":"0001171843-17-001109","document":"f4_land022417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001109/f4_land022417.xml","form_type":"4"}},{"id":4475945,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":138085,"kind":"person","name":"LAND RAYMOND J","position":1,"cik":"0001225613","reported_name":"LAND RAYMOND J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T21:08:59.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 27, 2018."}],"balance_after":16159,"source":{"system":"sec-edgar","filing":"0001171843-17-000588","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000588/formfour.xml","form_type":"4"}}]}